Albion Financial Group Dexcom Inc Transaction History

Albion Financial Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$114.22 - $140.1 $2,170 - $2,661	19 New	19 $2,000
Q2 2023 Jul 25, 2023	BUY	$112.47 - $130.98 $112 - $130	1 New	1 $0
Q2 2022 Jul 29, 2022	BUY	$67.99 - $132.89 $2,039 - $3,986	30 Added 300.0%	40 $3,000
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $940 - $1,302	-10 Reduced 50.0%	10 $5,000
Q4 2021 Feb 15, 2022	BUY	$129.87 - $162.82 $2,597 - $3,256	20 New	20 $11,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

Stay updated on Albion Financial Group with notifications on news.